Drug Database
Back to search

Czechia· CZ-0222387

FOTIVDA

A tivozanib product containing tivozanib hydrochloride monohydrate, registered in Czechia by Recordati Netherlands B.V., Schiphol-Rijk. The same ATC class is registered in 10 of our 19 countries.

ATC L01EK03

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedFOTIVDAATCL01EK03REGISTER NO.CZ-0222387PACKS LISTED0CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tivozanib hydrochloride monohydrateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tivozanib is registered in 10 of 19 countries.

Countries holding a registration under ATC L01EK03 (tivozanib), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 7 of them publish a price we can compare per daily dose
Search tivozanib products by name

Tivozanib · ATC L01EK03

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
TIVOZANIB HYDROCHLORIDE MONOHYDRATE
Manufacturer
Recordati Netherlands B.V., Schiphol-Rijk
Country
Czechia (CZ)
ATC code
L01EK03
ATC class
Tivozanib
Defined daily dose
1 mg, O
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

7 interactions on record for tivozanib.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tivozanib against other medicinesHow interaction checks work

Tivozanib · interactions on record

7 records

  • 3 severe
  • 4 moderate

Most severe, free to view

  • PhenobarbitalN03AA02severe
  • PhenobarbitalN05CA24severe
  • Hyperici herbaN06AX25severe
  • RiociguatC02KX05moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tivozanib in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tivozanib products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Fotivda
  • Liechtenstein · Fotivda
  • Norway · Fotivda

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d8d0b66c-5e41-4310-b8ff-ab54122ee48e
GET /v1/drugs/d8d0b66c-5e41-4310-b8ff-ab54122ee48e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "CPS DUR",
  "source": "sukl",
  "strength": "890MCG",
  "pack_size": "21",
  "substance": "TIVOZANIB HYDROCHLORIDE MONOHYDRATE",
  "cz_kod_sukl": "0222387",
  "product_type": "CH",
  "substance_codes": "21460",
  "registration_state": "R",
  "registration_number": "EU/1/17/1215/001"
}
API referenceMCP serverPlans

See everything about tivozanib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console